The nomination of Robert F Kennedy Jr by Trump to lead the Health Department has raised alarms among investors, causing significant declines in major pharmaceutical stocks, including Moderna and AstraZeneca.
Investors reacted sharply as RFK Jr's history as a prominent anti-vaccine activist threatens the future performance of pharmaceutical companies, highlighted by a 5% drop in Moderna shares alone.
Collection
[
|
...
]